No price history available.
Key financial summary
Financials in MYR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | MYRm | 419 | 464 | 618 | 669 | 918 | 875 | N/A | N/A |
| Operating profit | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | MYRm | 45 | 39 | 50 | 55 | 59 | 61 | N/A | N/A |
| EPS reported | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in MYR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Hextar Global Berhad operates as an investment holding company with diversified business interests spanning the manufacture, trade, and distribution of a wide variety of products. The company's activities are structured into three key segments: Agriculture products, Specialty chemicals, and Consumer products. Its agricultural division focuses on agrochemicals and fertilizers, with operations centered in Johor Bahru, and includes a comprehensive range of pesticides such as herbicides, insecticides, fungicides, rodenticides, and miticides. In the consumer market, Hextar Global produces and distributes disposable healthcare items, including wet wipes, tissues, and cotton-based products. Beyond these, the company is a significant provider of specialty chemicals, manufacturing and supplying a broad spectrum of products like surfactants, emulsifiers, demulsifiers, corrosion inhibitors, deoilers, and acid inhibitors. Its extensive chemical portfolio also encompasses institutional and industrial chemicals, detergents, sanitizing chemicals, chemical derivatives, coatings, liquid odorants, and dosing systems. Complementing these offerings, Hextar Global provides gas and chemical-related services, technical assistance, and engages in the trading of polymers, adhesive products, and machinery. Products are distributed through a robust network comprising independent distributors, major retailers like hypermarkets and supermarkets, and a wide array of authorized dealers. Founded in 1980, the company, headquartered in Klang, Malaysia, was formerly known as Halex Holdings Berhad before its name change in May 2019. Hextar Global Berhad is a subsidiary of Hextar Holdings Sdn Bhd.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Hextar Global Berhad (5151.KL)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Hextar Global Berhad operates as an investment holding company with diversified business interests spanning the manufacture, trade, and distribution of a wide variety of products. The company's activities are structured into three key segments: Agriculture products, Specialty chemicals, and Consumer products. Its agricultural division focuses on agrochemicals and fertilizers, with operations centered in Johor Bahru, and includes a comprehensive range of pesticides such as herbicides, insecticides, fungicides, rodenticides, and miticides. In the consumer market, Hextar Global produces and distributes disposable healthcare items, including wet wipes, tissues, and cotton-based products. Beyond these, the company is a significant provider of specialty chemicals, manufacturing and supplying a broad spectrum of products like surfactants, emulsifiers, demulsifiers, corrosion inhibitors, deoilers, and acid inhibitors. Its extensive chemical portfolio also encompasses institutional and industrial chemicals, detergents, sanitizing chemicals, chemical derivatives, coatings, liquid odorants, and dosing systems. Complementing these offerings, Hextar Global provides gas and chemical-related services, technical assistance, and engages in the trading of polymers, adhesive products, and machinery. Products are distributed through a robust network comprising independent distributors, major retailers like hypermarkets and supermarkets, and a wide array of authorized dealers. Founded in 1980, the company, headquartered in Klang, Malaysia, was formerly known as Halex Holdings Berhad before its name change in May 2019. Hextar Global Berhad is a subsidiary of Hextar Holdings Sdn Bhd.